Nitrasanata Dharma Tbk. vs Merck Tbk. — how do they compare? Nitrasanata Dharma Tbk. trades at Rp1,330 (market cap 4.57T, 11.02M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Nitrasanata Dharma Tbk. is far larger — about 2.7× Merck Tbk.'s market cap, and Nitrasanata Dharma Tbk. is more actively traded (11.02M versus 37.6K). Which is the better fit depends on your goals.
| JECX | MERK | |
|---|---|---|
Market Cap | 4.57T | 1.7T |
Volume | 11.02M | 37.6K |
Lot | 110.19K | 376 |
Turnover | 15.12B | 144.47M |
Average Price | 1,372.09 | 3,842.23 |
Value | 15.12B | 144.47M |
Indicative Equilibrium Price | 1,330 | 3,840 |
Indicative Equilibrium Volume | 2.04K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Nitrasanata Dharma Tbk (the Company) was established based on Notarial Deed No. 526 of Richardus Nangkih Sinulingga, S.H., dated November 28, 1990. The Company started its commercial operations in 1990. PT Magna Selaras Lestari is the controlling entity of the Company, and Dr. Darwan Madja Purba, SpM(K) as ultimate beneficial owner of the Company.
Read more on JECX →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →